4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001100682-26-000132
Chief Executive Officer sold 6,500 shares at $279.90 ($1,819,350)
- Chief Executive Officer acquired 6,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Girshick Birgit Chief Executive Officer | 2026-08-11 | Option exercise 10b5-1 | +6,500 | $179.66 | $1,167,790 | 42,513 | D |
| Girshick Birgit Chief Executive Officer | 2026-08-11 | Sale 10b5-1 | −6,500 | $279.90 | $1,819,350 | 36,013 | D |
| Derivatives | |||||||
| Girshick Birgit Chief Executive Officer | 2026-08-11 | Option exercise · Stock Options (Right to Buy) 10b5-1 | −6,500 | 0 | D | ||
| Open-market sales · 6,500 sh · avg $279.90 · $1,819,350 | |||||||
Loading xslF345X06/form4.xml…